Business

Workers facing debt, chronic illness, and financial stress are the most likely to remain in jobs for health benefits.

The switch for the easy-entry, second-row outer seats might stick and cause the seats to unlatch, tip, or slide abruptly, the company said.

Medicare Part D now caps annual out-of-pocket prescription drug costs, offering greater financial protection for beneficiaries.

OpenAI said the autonomous models penetrated Hugging Face’s servers while searching for secret information that could help them pass an evaluation.

London has finalized legislation to seize the Chinese-owned company as G7 nations increasingly prioritize economic security over market forces.

The European Investment Bank’s largest-ever corporate loan has drawn fresh attention to a two-decade-old U.S.–EU dispute over aircraft subsidies.

Treasury Inflation-Protected Securities can help shield your savings from inflation, but they also carry risks investors shouldn’t overlook.

The volume of Australian businesses going into administration each continues has rocketed since the pandemic.

The tariff is intended to encourage the reshore America’s pharmaceutical supply chain and protect national security.

Although there are still 300,000 fewer homes priced under $350,000 on the market than in 2019, the gap has narrowed by 220,000 homes since 2022.

The company raised its full-year 2026 earnings forecast on strong second-quarter results, led by pickup sales.

Artificial intelligence has cannibalised online content but news organisations are being warned they must take a leading role in shaping it.

If the case had gone to trial, the company could have been liable for tens of billions in damages.

Manufacturing sectors in California and Texas were the biggest beneficiaries of President Donald Trump’s landmark bill.

If the bill to end congressional stock trading passes the House, it would likely have an uphill climb in the Senate, where 60 votes are needed.

The latest levies target almost $20 billion in Canadian goods, or 0.8 percent of GDP.

The two companies are battling over advertisements comparing their flagship obesity and diabetes medications.